At 8 weeks follow up, PTFE-treated mice show increased ventricular expression of the novel hypoxia marker KDM6A, mild systolic and diastolic contractile dysfunction, signs of cardiac eccentric hypertrophy and pulmonary edema, that were accompanied by CaMKII overexpression. Here, KDM6A is linked to pulmonary edema.